Acute Renal Failure clinical trials
55 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
- Nafamostat Efficacy in Phase 3 Registrational CRRT Study
- Improving Preterm Kidney Outcomes With Caffeine
- Prevent Cardiac Surgery Associated AKI Trial
- Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
- Ultra-Low Contrast Angiography in AKI
- LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM)
- SAfety of Regional Citrate Anticoagulation (SARCA Study)
- Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
- Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
- Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
- The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)
- The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
- Initial Resuscitation for Acute Kidney Injury in Cirrhosis
- Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome
- Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial
- Melatonin for Prevention of Kidney Injury
- NIRS Monitoring in the NICU and AKI
- Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial)
- Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury
- Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
- Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy
- NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- The Biosonographic Index
- FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids
- Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury
- Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support
- Prospective Validation of AKI Prediction
- A Comparison of Renal vs Limb NIRS for Predicting Cardiac Surgery Associated Acute Kidney Injury
- QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
- Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients
- Cardiopulmonary Bypass Induced Red Blood Cell Lysis
- KIDney Injury in Times of COVID-19 (KIDCOV)
- Kidney Function in People With Cystic Fibrosis in the Era of HEMT
- Optimizing Pulsatility During Cardiopulmonary Bypass
- Kidney Precision Medicine Project
- Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
- Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System
- A Study of Facilitators and Barriers to Improve Acute Kidney Injury in Children Through Mobile Health Intervention
- A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
- Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2
- Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness
- Amino Acids for Cardiac Surgery Associated AKI
- Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression
- Point-of-Care AI Assistance and Critical Care Outcomes: A Randomized Trial
- Real-Time Acute Kidney Injury Perioperative Prediction Clinical Trial
- A Prompt REstart Study of Renin-Angiotensin System Inhibitors After Acute Kidney Injury
- Infliximab for Immune Checkpoint Inhibitor Associated AKI
- Precision-Medicine Diagnostic Support in Hospitalized Veterans With Acute Kidney Injury
- Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric AKI
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Acute Renal Failure” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.